APA (7th ed.) Citation

LK, Z., Y, S., H, Z., Q, W., X, J., WJ, S., . . . G, X. (2021). Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell discovery, 7(1), 29. https://doi.org/10.1038/s41421-021-00267-0

Chicago Style (17th ed.) Citation

LK, Zhang, et al. "Author Correction: Calcium Channel Blocker Amlodipine Besylate Therapy Is Associated with Reduced Case Fatality Rate of COVID-19 Patients with Hypertension." Cell Discovery 7, no. 1 (2021): 29. https://doi.org/10.1038/s41421-021-00267-0.

MLA (9th ed.) Citation

LK, Zhang, et al. "Author Correction: Calcium Channel Blocker Amlodipine Besylate Therapy Is Associated with Reduced Case Fatality Rate of COVID-19 Patients with Hypertension." Cell Discovery, vol. 7, no. 1, 2021, p. 29, https://doi.org/10.1038/s41421-021-00267-0.